Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Cybin to Participate in the Cantor Global Healthcare Conference


Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that Doug Drysdale, Chief Executive Officer of Cybin, and George Tziras, Chief Executive Officer of Small Pharma Inc., will participate in a panel discussion titled "Emerging Therapeutic Candidates for Mental Health" at the Cantor Global Healthcare Conference, taking place September 26-28, 2023 in New York City, NY.

The panel will be webcast live on Thursday, September 28, 2023 at 1:15 p.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company's investor relations website on the Events & Presentations page.

About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin's goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.


These press releases may also interest you

at 06:10
Masan High-Tech Materials (HNX-UpCOM: MSR, "Masan High-Tech Materials", "MHT" or "Company") today announced that it had reached a framework agreement with Mitsubishi Materials Corporation Group ("MMC Group", and together with MHT, the "Parties"):...

at 06:08
TurfUSA.com unveils its revamped website, introducing its updated line of Artificial Ivy's and vertical garden's and also its new high-end luxurious synthetic Turf "Lush 101" and ultra soft "Lush Empire", both premium quality synthetic turf products....

at 06:06
Loqate (a GBG solution), the leader in global address verification, today announced the release of its Address Verification solution for Shopify Plus. This integration offers Shopify Plus merchants an accurate way to capture, verify and enrich global...

at 06:05
Jumio, the leading provider of automated, AI-driven identity verification, risk signals and compliance solutions, today released the Jumio 2024 Online Identity Study, the third installment of its annual global consumer research. This year's results...

at 06:05
FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its Helicontm peptide platform, and ARTBIO, Inc. ("ARTBIO"), a clinical-stage...

at 06:05
HYAS Infosec, an adversary infrastructure platform provider that offers unparalleled visibility, protection and security against all kinds of malware and attacks, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today...



News published on and distributed by: